Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2012

View Archived Issues

Radius Health scientists design novel SARMs

Roche presents new potential products to treat/prevent CMV infection

Biota Holdings presents novel antibacterials

Interferon-free combination therapy shows promise to treat chronic hepatitis C

Encouraging phase I data reported on candidate arthritis immunotherapy

Pretargeted radioimmunotherapy is safe, specific and fast in patients with colorectal tumors

Korean team discovers novel serum biomarker of ovarian carcinoma

Genocea Biosciences presents potential HSV-2 vaccine at ongoing conference

Proteostasis Therapeutics to collaborate with CFFT

Interim data reported from combination study in CF

Sunovion confirms upcoming availability of ciclesonide nasal aerosol

Iluvien gains U.K. marketing authorization

Aeterna Zentaris regains rights to perifosine

Galleon Pharmaceuticals reports phase I GAL-021 study results

FDA clears p53 image analysis algorithm

Alder BioPharmaceuticals launches phase I trial of mAb for migraine

German BfArM issues recommendation on Pliaglis MAA

Santen and Bayer Yakuhin enter copromotion agreement

First-in-human data disclosed on topical RNAi drug for ocular pain

New phase III study of Adcetris begins

Immunomic Therapeutics clear to launch phase I trial of Japanese red cedar allergy vaccine

New candidate drugs for tuberculosis designed at GSK

Investigation at Roche yields novel TWEAK-specific antibodies

Envoy Therapeutics receives second grant from Michael J. Fox Foundation

FDA extends PDUFA date for Marqibo NDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...